Nous sommes un groupe pharmaceutique à dimension humaine, international et indépendant, gouverné par une Fondation. Notre modèle, singulier, fait notre fierté mais, surtout, nous permet de servir pleinement notre vocation : « Engagés pour le progrès thérapeutique au bénéfice des patients ».
Aujourd’hui leader mondial en cardiologie, nous avons choisi de devenir un acteur focalisé et innovant en oncologie d’ici 2030, en ciblant des cancers difficiles à traiter et en y consacrant plus de 70 % de notre budget R&D. Un défi que nous poursuivons en parallèle du développement de notre activité générique pour un accès à des soins de qualité pour tous, et à moindre coût.
Nous ? 22 000 passionnés de plus de 50 nationalités, portés par un esprit d’entreprenariat. Chaque jour nous avançons avec et pour les patients, avec et pour nos équipes, portés par l’envie de prendre soin, d’oser, de nous développer, de nous engager pour être utiles à celles et ceux qui en ont besoin.
Venez vivre et contribuez à faire vivre notre engagement #MovedByYou
ORIL Industrie (1000 employees), the 2nd largest chemical industrial site in France, a subsidiary of the SERVIER Group committed to therapeutic progress for the benefit of patients, is a strategic chemical production site in the pharmaceutical field.
Thanks to its know-how and cutting-edge expertise, the site produces nearly 2,000 tonnes of active ingredients each year, intended in particular for medicines prescribed in the fields of cardiology, oncology, neuropsychiatry, diabetes, and venous insufficiency.
The particularity of the Bolbec site is that it has both an industrial production activity and an R&D center dedicated to developing the chemical syntheses of new drugs.
As a responsible employer, we encourage diversity within our teams and are committed to employing people with disabilities.
We are located in Normandy, in Bolbec, between Le Havre (35 minutes) and Rouen (50 minutes), in a pleasant and green setting 30 minutes from the sea.
What if your next role had a direct impact on future medicines?
At Servier, within the Chemical Development department, we are convinced that scientific innovation transforms patients' lives. Every day, we push the boundaries of chemistry to develop robust, sustainable, and industrializable processes.
Located at our Bolbec site (Normandy), you will join a dynamic environment at the heart of CMC (Chemistry, Manufacturing & Controls) activities, working in close collaboration with analytical, formulation, quality, and industrial teams.
As Process Chemistry Team Leader, you will lead and inspire a team of approximately 10 scientists (a mix of Research Engineers/PhDs and Technicians) dedicated to the design, optimization, and scale-up of synthetic processes for future drug candidates.
Operating at the interface between R&D and Industry, you will be a key player in the CHAD (Chemical and Analytical Development) department, managing activities for small molecules, ASOs, and ADCs.
We are looking for a leader who can create a positive, performance-oriented team dynamic.
Why Join Servier in Bolbec?
Nous sommes engagés pour l’égalité des chances et le développement des talents dans toute leur diversité. Nous accordons autant de valeur à l’expérience qu’à l’envie de s’engager au quotidien pour être utile au progrès thérapeutique au bénéfice des patients. Si vous vous reconnaissez dans cette offre et ces quelques lignes, saisissez cette opportunité de nous rencontrer.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle.
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D.
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.
--
To report a suspected adverse event with a Servier drug, please visit servier.com